Plus Therapeutics Announces Presentation Of ReSPECT-GBM Trial Dosimetery Data At American Society For Radiation Oncology (ASTRO) 2021 Annual Meeting
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today